ELEV
Elevation Oncology
ELEV
ELEV
Delisted
ELEV was delisted on the 22nd of July, 2025.
27 hedge funds and large institutions have $13.7M invested in Elevation Oncology in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
15% less capital invested
Capital invested by funds: $16.1M → $13.7M (-$2.44M)
Holders
27
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$456K | |
| 2 | +$19.2K | |
| 3 | +$4K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.69K |
| 5 |
BlackRock
New York
|
+$642 |
Top Sellers
| 1 | -$253K | |
| 2 | -$84.4K | |
| 3 | -$44K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7.27K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$1K |